Akums Drugs and Pharmaceuticals share news and announcements
NSE: AKUMSBSE: 544222Pharmaceuticals & BiotechnologySmall Cap
Last close ₹669.00down ₹11.20 (1.65%)BSE ₹668.10
Share price at the NSE close on 23 Oct 2026. Previous close ₹680.20.
52-week range of traded prices to 23 Oct 2026
₹409.30Low, 21 Jan 2026₹838.80High, 23 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹10,530 Cr630th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 8 Aug 2026
- 36.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 14 May 2026
- 3.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.45%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 8 Aug 2026
- 9.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 8 Aug 2026
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 14 May 2026
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,89,38152.3% delivered
Akums Drugs and Pharmaceuticals share news and announcements
151 announcements, routine notices left out, newest first. Page 3 of 4.
May 2025
14 May · Business
Mar 2025
18 Mar · Meeting
4 Mar · Analysts
1 Mar · Analysts
Feb 2025
14 Feb · Meeting
11 Feb · Analysts
11 Feb · Business
6 Feb · Results
6 Feb · Board meeting
3 Feb · Analysts
Jan 2025
23 Jan · Updates
22 Jan · Updates
2 Jan · Updates
Dec 2024
Nov 2024
14 Nov · Meeting
12 Nov · Analysts
11 Nov · Analysts
9 Nov · Board meeting
5 Nov · Analysts
Oct 2024
9 Oct · Business
9 Oct · Rating
Sep 2024
12 Sep · Updates
Aug 2024
24 Aug · Board meeting
23 Aug · Analysts
20 Aug · Legal
The exchange asked on 19 Aug 2024